Fredrick Chite Asirwa: Honored to Receive the National Cancer Institute of Kenya’s Excellence in Research, Training and Care Award
Fredrick Chite Asirwa, Chairman of the Board at Global multicenter Clinical Trial, shared a post on LinkedIn:
“Deeply honored, at the just concluded 2nd National Cancer Summit 2025, to receive the National Cancer Institute of Kenya’s Excellence in Research, Training and Care Award for contributions to cancer control, training and research in Kenya and the region. Grateful to the National Cancer Institute of Kenya, Ministry of Health, Kenya, CEO DR. Elias Melly its Board membership, our International Cancer Institute team, collaborating partners and colleagues for their unwavering support.
This recognition reflects our collective mission, passion and dedication to advance equity, improve outcomes and support our communities across the continuum of their cancer journeys from prevention, screening, early detection, optimal diagnostics and therapeutics, palliative care, survivorship care and research!
I’m more committed than ever to advancing our fight against cancer and hematological disorders. This award is to the patients who inspire me daily.”
More posts featruing Fredrick Chite Asirwa.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023